It is an excellent source for your DD........................
https://www.chinahealthlabs.com/downloads/CHO%20presentation%20-%20April2011.pdf
Some major points................
................Chairman owns 62 % of the shares, which means his value emhamcement objectives are aligned with that shareholders
.................CHO has very little competiton in China, as it has been in existence since 1993 and due also to the long certification process
..............per capital health expenditures are less than 1 % of those in developed countries. As with car ownership, this disparity will narrow considerably over the next few years
...........40,000 new hospitals are planned for the next 5 years providing CHO with strong growth opportunities
............CHO provides both its own and non-Chinese lab products and is the exclusive distributor in China for many of these
..........as the number of labs sold increases, there will be an exponential increase in recurring revenues for CHO
..............CHO forecasts strong growth in both sales and net earnings in 2011.
Being first-to-the-post as an entrenched and innovative healthcare product provider in China gives CHO a huge advantage over its competitors.
2011 looks to be a record year..